← Back to contracts

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

US National Institutes of Health (NIH) — likely National Cancer Institute (NCI) grant unknown #grants-gov-PAR-25-098
Response due Jan 07, 2027 · 00:00 UTC

Summary

This is a federal grant opportunity (R01) issued through Grants.gov seeking research proposals for interventions designed to expand cancer screening and preventive services among populations that experience health disparities. A clinical trial is required as part of the research design. The program aligns with the ADVANCE (Advancing Diverse and Necessary Cancer Equity) initiative or similar health equity frameworks. Applicants are expected to design, implement, and evaluate evidence-based strategies that reduce disparities in access to and uptake of cancer screening and prevention services.

What they want

Technical requirements
  • Clinical trial design is required (not optional)
  • Research must target populations that experience health disparities
  • Interventions must address cancer screening and/or preventive services

Risks & flags

  • No dollar values, dates, or eligibility details provided in source text — unable to verify open/closed status or award ceiling
  • Insufficient source text to assess for wired-bidder indicators; full FOA text should be reviewed

Market context

inferred from NAICS
R&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)
NAICS 541715
US market size
$95B
Typical award
$100K – $50M+
Typical buyers
DoDNSFNIHNASADOE
Commonly required
DCAA-compliant accountingITARCMMC L2
Interventions to expand cancer screening a…
Due Jan 07
Onboard